Structural basis of Mos1 transposase inhibition by the anti-retroviral drug raltegravir

Wolkowicz, U.M.; Morris, E.R.; Robson, M.; Trubitsyna, M.; Richardson, J.M.

doi:10.1021/cb400791u

All Outputs (3)

A sequence-based approach for prediction of CsrA/RsmA targets in bacteria with experimental validation in Pseudomonas aeruginosa (2014)
Journal Article
Kulkarni, P., Jia, T., Kuehne, S., Kerkering, T., Morris, E., Searle, M., …Kulkarni, R. (2014). A sequence-based approach for prediction of CsrA/RsmA targets in bacteria with experimental validation in Pseudomonas aeruginosa. Nucleic Acids Research, 42(11), 6811-6825. https://doi.org/10.1093/nar/gku309

Biochemical characterization and comparison of two closely related active mariner transposases (2014)
Journal Article
Trubitsyna, M., Morris, E., Finnegan, D., & Richardson, J. (2014). Biochemical characterization and comparison of two closely related active mariner transposases. Biochemistry, 53(4), 682-689. https://doi.org/10.1021/bi401193w

Structural basis of Mos1 transposase inhibition by the anti-retroviral drug raltegravir (2014)
Journal Article
Wolkowicz, U., Morris, E., Robson, M., Trubitsyna, M., & Richardson, J. (2014). Structural basis of Mos1 transposase inhibition by the anti-retroviral drug raltegravir. ACS Chemical Biology, 9(3), 743-751. https://doi.org/10.1021/cb400791u